 |
| courtesy:Cardiff University |
Alesi
Surgical Limited, leading innovator of Minimally Invasive Technology gains FDA
approval for its Ultravision system. It is world’s first technology that not
only clears surgical smoke, but eliminates it to improve visibility of the
surgical field. Particulate matter and smoke is generated by cutting
instruments during the modern laparoscopic abdominal surgeries obscuring the surgical
field.
Dr Dominic
Griffiths, Managing Director of Alesi Surgical said “We are thrilled to have
gained FDA approval for our Ultravision system that will now allow us to enter
the US market. Commercially the US represents approximately fifty per cent of
the global medical device market and so it is difficult to overstate the
importance of this for the company.”
When a
surgeon uses Ultravision, the surgery is quick, requires few lens cleaning along
with significantly less use of carbon dioxide. Keyhole surgeries are known to
use several hundred liters of carbon dioxide to get a clear vision of the
surgical field, which prolongs the recovery time and causes post-surgical pain.
The Ultravision
system works by producing negatively charged gas ions in the abdominal cavity,
which move towards the “positive” patient tissue. As the ions move, they
collide with water vapour and particulate matter and draw them away from the
surgical site. Particles land, and the electrical charge flows back to the
generator.
After 1
minute of continuous use, smoke evacuation removes 30.2% of particles (by
number) In the same time period Ultravision™ precipitated 99.9% of particles,
independent of particle size, from 7nm to 10µm (p<0.05).
It is
estimated that over seven million abdominal keyhole procedures are performed
annually, worldwide.
The video demonstrates
the mode of action of Ultravision.
